SCHEMBL31408301

SCHEMBL31408301

CNC(=O)NCc1cc2cc(Cl)c(-c3cnc(OC)cn3)cc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ PTGES O14684 4/20 0.35
▸ MAPT P10636 2/20 0.34
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ ATP6AP1 Q15904 1/20 0.32
▸ MTNR1A P48039 4/20 0.32
▸ MTNR1B P49286 4/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HTT P42858 1/20 0.31
▸ KCNH2 Q12809 2/20 0.31
▸ SCN5A Q14524 2/20 0.31
▸ SCN9A Q15858 2/20 0.31
▸ RECQL P46063 1/20 0.31
▸ KDM4A O75164 1/20 0.31
▸ KDM5A P29375 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408457 0.90 SMN1; SMN2 (0.42) SMN1; SMN2PTGESMAPTLOXL2PRKAG1
SCHEMBL31408575 0.90 SMN1; SMN2 (0.52) SMN1; SMN2PTGESMAPTLOXL2PRKAG1
SCHEMBL31408481 0.90 SMN1; SMN2 (0.39) SMN1; SMN2PTGESMAPTLOXL2PRKAG1
SCHEMBL31408480 0.90 SMN1; SMN2 (0.39) SMN1; SMN2PTGESMAPTLOXL2PRKAG1
SCHEMBL31408438 0.89 SMN1; SMN2 (0.41) SMN1; SMN2PTGESMAPTLOXL2PRKAG1
SCHEMBL31408413 0.89 SMN1; SMN2 (0.36) SMN1; SMN2MAPTLOXL2MTNR1AMTNR1B
SCHEMBL31408525 0.89 MAPK1 (0.39) SMN1; SMN2PTGESKCNH2SCN5ASCN9A
SCHEMBL31408478 0.89 SMN1; SMN2 (0.39) SMN1; SMN2PTGESMAPTLOXL2PRKAG1
SCHEMBL31408262 0.88 MTNR1A (0.43) SMN1; SMN2PTGESLOXL2MTNR1AMTNR1B
SCHEMBL31408624 0.88 SMN1; SMN2 (0.40) SMN1; SMN2PTGESMAPTLOXL2PRKAG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback